# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-025201
Filing Date
2025-11-26
Accepted
2025-11-26 17:26:57
Documents
67
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1124332
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 19854
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 19721
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 10607
| Complete submission text file | 0001493152-25-025201.txt |  | 5507018

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ptix-20250930.xsd | EX-101.SCH | 41699
6 | XBRL CALCULATION FILE | ptix-20250930_cal.xml | EX-101.CAL | 56113
7 | XBRL DEFINITION FILE | ptix-20250930_def.xml | EX-101.DEF | 200552
8 | XBRL LABEL FILE | ptix-20250930_lab.xml | EX-101.LAB | 345542
9 | XBRL PRESENTATION FILE | ptix-20250930_pre.xml | EX-101.PRE | 277710
69 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 759968

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 251531574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)